Dan Sheng
Direttore/Membro del Consiglio presso BEIJING STRONG BIOTECHNOLOGIES,INC.
Patrimonio netto: 907 594 $ in data 30/04/2024
Posizioni attive di Dan Sheng
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Direttore/Membro del Consiglio | 13/08/2020 | - |
| Corporate Officer/Principal | 01/12/2016 | - | |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Direttore/Membro del Consiglio | 30/09/2020 | - |
Storia della carriera di Dan Sheng
Formazione di Dan Sheng
| University of Science & Technology of China | Undergraduate Degree |
| New York University | Doctorate Degree |
| The University of Chicago | Masters Business Admin |
Statistiche
Distribuzione geografica
| Cina | 4 |
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Borsa valori
- Insiders
- Dan Sheng
- Esperienza